Lv4
664 积分 2025-05-14 加入
Abstract P5-18-08: The relative risk of various endocrinopathies associated with neoadjuvant chemoimmunotherapy use in early-stage triple-negative breast cancer: A systematic review and meta-analysis
5小时前
求助中
Immunotherapy related patient-reported outcomes from five randomized controlled trials in patients with triple negative breast cancer: A systematic review
5小时前
求助中
Abstract PS9-18: Relative risk of various endocrinopathies associated with the use of chemoimmunotherapy for triple-negative breast cancer: A systematic review and meta-analysis
5小时前
求助中
223P Pathologic complete response (pCR) as a surrogate endpoint for long-term survival in early triple-negative breast cancer (eTNBC) treated with neoadjuvant immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis of randomized controlled trials (RCTs)
5小时前
求助中
258P Immune checkpoint inhibitors addition to chemotherapy in older patients with metastatic triple-negative breast cancer: A systematic review and meta-analysis
5小时前
待确认
Abstract P5-18-14: The relative risk of pneumonitis associated with neoadjuvant chemoimmunotherapy use in early-stage triple-negative breast cancer: A systematic review and meta-analysis
5小时前
求助中
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
5小时前
已完结
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis
5小时前
已完结
AIOM Abstract
5小时前
已完结
Immune checkpoint inhibitors as neoadjuvant therapy in early triple-negative breast cancer: A systematic review and meta-analysis
5小时前
已完结
皖公网安备34019202002308
